Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2021 | The antibody treatment landscape in myeloma

Sagar Lonial, MD, Winship Cancer Institute of Emory University, Atlanta, GA, gives an overview of the antibody treatment landscape for multiple myeloma, highlighting the approval of isatuximab and belantamab mafodotin and the future role of bispecific antibodies. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.